Semmelweis University — Sponsor Intelligence | 13 EU Trials

Filter these 13 trials by condition, phase, country and more.

Open in Search →

13 Registered trials

3 Recruiting

1 Completed trials

4 Countries active

28 Unique IMPs

100% Results reported

Phase IV

Phase II/III: 1 Phase IV: 12

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Bronchopulmonary dysplasia 1 Neonatal respiratory failure 1 Dyslipidaemia 1 Coronary artery disease 1

Top IMPs

ATEZOLIZUMAB 1 CEFEPIME DIHYDROCHLORIDE MONOHYDRATE 1 CEFTRIAXONE 1 CEFTRIAXONE SODIUM 1 DURVALUMAB 1 FENTANYL 1 FENTANYL CITRATE 1 INCLISIRAN 1 IPILIMUMAB 1 LIQUID EXTRACT OF THYME (1:3.45-3.85), EXTRACTION SOLVENT: ETHANOL 27%(V/V) 1 LYOPHILIZED BACTERIAL LYSATES OF: HAEMOPHILUS INFLUENZAE STREPTOCOCCUS (DIPLOCOCCUS) PNEUMONIAE KLEBSIELLA PNEUMONIAE AND OZAENAE STAPHYLOCOCCUS AUREUS STREPTOCOCCUS PYOGENES AND VIRIDANS MORAXELLA (BRANHAMELLA / NEISSERIA) CATARRHALIS 1 MEROPENEM 1

All trials

13 total

Normal saline versus lactated Ringer’s solution for fluid administration in acute pancreatitis, an open-label multicenter randomized control… Pending

2024-511229-79-00 Phase IV 1 country POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE DIHYDRATE, SODIUM LACTATE;…
ALLIC 2022 international clinical investigation for advanced management of childhood acute lymphoblastic leukemia Pending

2024-513824-41-00 Phase IV 4 countries PEGASPARGASE; RITUXIMAB
Comparing the efficacy and safety of extended (3 h) and intermittent infusion (0.5 h) of beta-lactams (cefepime, ceftriaxone, meropenem, pip… Pending

2024-518115-19-02 Phase IV 1 country CEFEPIME DIHYDROCHLORIDE MONOHYDRATE; CEFTRIAXONE; CEFTRIAXONE SODIUM; MEROPENEM…
Questionary to Fentanyl Nasal (F-PUFF) Spray Efficiancy and Safety Pending

2024-519131-42-02 Phase IV 1 country FENTANYL; FENTANYL CITRATE
Effect of preoperative intramasseteric methylprednisolone injection on the post-operative sequelae of lower third molar surgery: a placebo c… Pending

2024-520422-11-00 Phase IV 1 country METHYLPREDNISOLONE HEMISUCCINATE
Comparison of the preventive painkiller effect of etoricoxib and celecoxib after M3M surgery: A randomized, double-masked clinical trial Pending

2025-520695-26-00 Phase IV 1 country
Assessing the efficacy of Elixirium thymi compositum in the treatment of acute bronchitis in pediatric patients (EXOTIC): A double-blind, ra… Pending

2025-520845-61-00 Phase IV 1 country LIQUID EXTRACT OF THYME (1:3.45-3.85), EXTRACTION SOLVENT: ETHANOL 27%(V/V)
Changes in plaque characteristics after short-term statin therapy assessed with coronary CT (INTENSE) Pending

2025-522868-32-00 Phase II/III 1 country ROSUVASTATIN
The effect of Broncho-Vaxom on the COPD exacerbations in terms of lung function, lung mechanics, immune state, body composition, quality of … Pending

2025-524501-32-02 Phase IV 1 country LYOPHILIZED BACTERIAL LYSATES OF: HAEMOPHILUS INFLUENZAE STREPTOCOCCUS (DIPLOCOC…
The Role of Beta-Blockade During Cardiac CT in Patients with Atrial Fibrillation Recruiting

2025-523391-22-01 Phase IV 1 country
BudapestICIVasc: Cardiovascular side effects of immune checkpoint inhibitor oncological therapies and their monitoring in the context of onc… Recruiting

2025-523620-44-02 Phase IV 1 country ATEZOLIZUMAB; DURVALUMAB; IPILIMUMAB; NIVOLUMAB; PEMBROLIZUMAB
The effect of additional pre-extubational loading dose of caffeine-citrate Recruiting

2024-519041-29-02 Phase IV 1 country
Semmelweis Lipid Center for High-risk Patients Ended

2024-519058-35-00 Phase IV 1 country INCLISIRAN

Showing 1–13 of 13 trials

← All sponsors A–Z